PSIL vs. SURI ETF Comparison

Comparison of AdvisorShares Psychedelics ETF (PSIL) to Simplify Exchange Traded Funds Simplify Propel Opportunities ETF (SURI)

PSIL

AdvisorShares Psychedelics ETF

PSIL Description

AdvisorShares Trust - AdvisorShares Psychedelics ETF is an exchange traded fund launched and managed by AdvisorShares Investments, LLC. The fund invests in public equity markets of global region. It invests directly and through derivatives in stocks of companies operating across healthcare, pharmaceuticals, biotechnology and life sciences companies focused on plant-based psychedelic medicines as well as other companies with business activities in the psychedelics industry sectors. The fund uses derivatives such as swaps to create its portfolio. It invests in growth and value stocks of companies across diversified market capitalization. The investment seeks long-term capital appreciation. AdvisorShares Trust - AdvisorShares Psychedelics ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$1.04

Average Daily Volume

50,657

Number of Holdings ^*

9

* may have additional holdings in another (foreign) market

SURI

Simplify Exchange Traded Funds Simplify Propel Opportunities ETF

SURI Description

The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$23.79

Average Daily Volume

3,475

Number of Holdings ^*

9

* may have additional holdings in another (foreign) market

Performance

Period	PSIL	SURI
30 Days	10.64%	10.85%
60 Days	-12.61%	12.43%
90 Days	-19.38%	10.23%
12 Months	-45.21%	26.20%

0 Overlapping Holdings

	Symbol	Grade	Weight in PSIL	Weight in SURI	Overlap

PSIL Overweight 9 Positions Relative to SURI

	Symbol	Grade	Weight
	MNMD	C	18.11%
	CYBN	F	8.63%
	CMPS	D	7.77%
	RLMD	D	5.74%
	ALKS	B	5.1%
	ATAI	D	5.09%
	ITCI	B	4.64%
	GHRS	C	4.44%
	SAGE	F	2.78%

PSIL Underweight 9 Positions Relative to SURI

	Symbol	Grade	Weight
	PAGP	B	-26.62%
	APLT	B	-13.56%
	MDGL	C	-6.73%
	TCRX	D	-6.31%
	PHAT	C	-5.54%
	RNA	C	-5.26%
	AKRO	C	-5.14%
	ARDX	F	-4.57%
	ATHA	C	-4.08%

PSIL: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Care Facilities

Keywords: Biopharmaceutical Drugs Entheogens Major Depressive Disorder Mental Health Neurochemistry Psychoactive Drugs Biotechnology Depressive Disorder Drug Development Hyperactivity Disorder N Dimethyltryptamine Neuroscience Psychedelic Drug Psychiatric And Neurological Disorders Psychiatry Schizophrenia Treatment Resistant Depression Adjunctive Therapy Aging Associated Diseases

SURI: Top Represented Industries & Keywords

Industries: Biotechnology Oil & Gas Midstream

Keywords: Biopharmaceutical Biotechnology Life Sciences Metabolic Disease Cancer Gastrointestinal Medication Acid Alcohol Biopharmaceutical Products Brain Disorders Cardiomyopathy Cardiovascular And Metabolic Diseases Cardiovascular Disease Chemical Substances Cholesterol Chronic Kidney Disease Clinical Trial Constipation Crude Oil